维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="ZIEMSSEN F"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Bevacizumab for treatment of macular edema secondary to retinal vein occlusion显示文摘	Jaissle GB Ziemssen F Petermeier K	2006	Ophthalmologe2006，103，：	1
2	Weak transient response of chronic uveitic macular edema to intrav- itreal bevacizumab ( Avastin ) 显示文摘	ZIEMSSEN F DEUTER C M STUEBIGER N	2007	Graefes Arch Clin Exp Ophthalmo12007，245，6：	1
3	Blinking activity during display terminal work显示文摘	Ziemssen F Freudenthaler N Regnery K	2005	Ophthalmologe2005，102，：	1
4	Safety,penetration and efficacy of topically applied bevacizumab:evaluation of eyedrops in corneal neovascularization after chemical burn显示文摘	Yoeruek E Ziemssen F Henke-Fahle S	2008	Acta Ophthalmol2008，86，：	1
5	Bevacizumab for treatment of macular edema secondary to retinal vein occlusion 显示文摘	Jaissle GB Ziemssen F Petermeier K	2006	Ophthalmol2006，103，6：	1
6	Morphological features of my- opic choroidal neovascularization :differences to neovascular age-related macular degeneration显示文摘	INHOFFEN W ZIEMSSEN F	2012	Ophthalmologe2012，109，8：	1
7	The international intravitreal bevacizumab safety survey显示文摘	Ziemssen F Grisanti S Bartz-Schmidt KU	2006	Br J Ophthalmol2006，90，：	1
8	Safety, penetration and efficacy of topically applied bevacizumab: Evaluation of eyedrops in corneal neovascularization after chemical burn 显示文摘	Yoeruek E Ziemssen F Henke-Fahle S Tatar O Tufa A Grisanti S	2008	Acta Ophthalmologica Scandinavica2008，85，3：	1
9	Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab显示文摘	Peters S Heiduschka P Julien S Ziemssen F Fietz H BartzSchmidt KU	2007	Am J Ophthalmol2007，143，6：	1
10	Intravitreal bevacizumab (avastin)for occult choroidal neovascularization in age-related macular degeneration显示文摘	Aisenbrey S Ziemssen F Volker M	2007	Graefes Arch Clin Exp Ophthalmol2007，245，7：	1
11	Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization显示文摘	Zhu Q Ziemssen F Henke-Fahle S Tübingen Bevacizumab Study Group	2008	Ophthalmology2008，115，10：	1
12	Intravitreal bevacizumab for iris rubeosis 显示文摘	Grisanti S Biester S Peters S Tatar O Ziemssen F Bartz-Schmidt KU	2006	Am J Ophthalmol2006，142，5：	1
13	Intracameral bevacizumab for iris rubeosis 显示文摘	Grisanti S Biester S Peters S Tatar O Ziemssen F Bartz-Schmidt KU	2006	Am J Ophthalmol2006，142，1：	1
14	The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis ( EAE ) 显示文摘	Ziemssen T Ziemssen F	2005	Autoimmun Rev2005，4，7：	1
15	Intravitreally bevacizumab (avastion) for occult choroidal neovascularization in to age-related macular degeneration显示文摘	Aisenbrey S Ziemssen F Vlker M	2007	Grafes Arch Clin Exp Ophthalmol2007，247，12：	1
16	Vitreous lev- els of bevacizumab and vascular endothelial growth fac- tor-A in patients with choroidal neovascularization 显示文摘	Zhu Q Ziemssen F Henke-Fahle S	2008	Ophthalmology2008，115，10：	1
17	Safety penetration and efficacy of topically applied bevacizumab : evaluation of eyedrops in corneal neovascularization after chemical burn 显示文摘	Yoeruek E Ziemssen F Henke-Fahle S Tatar O Tura A Grisanti S	2008	Acta Ophthalmol2008，86，3：	1
18	Analysis of neovasculature in uveal melanoma by targeting the TGF~ - binding receptor endog- lin : is there prognostic rdevance of proliferating endothdium? 显示文摘	Ziemssen F Wegner R Wegner J	2006	Graefes Arch Clitl Exp Ophthalmo12006，244，9：	1
19	Re: de- velopment of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration显示文摘	ZIEMSSEN F HEIDUSCHKA P SCHRAERMEYER U	2007	Retina2007，27，8：	1
20	Intravitreally bevacizumab(Avastion)for occult choroidal neovascularization in to age-related macular degeneration显示文摘	Aisenbrey S Ziemssen F Vlker M		0，，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示